Condition 1: opioid induced pruritus. Condition 2: nausea and vomiting. Pruritus, unspecified Vomiting of pregnancy, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Immediately after clamping the umbilical cord for first study group ondansetron 4 mg (Exir Company) by intravenous will be injected. Intervention 2: Intervention
Treatment - Drugs
Intervention group 1: Immediately after clamping the umbilical cord for first study group ondansetron 4 mg (Exir Company) by intravenous will be injected.
Intervention group 2: Immediately after clamping the umbilical cord for second study group 10 mg propofol (Fresnius Kabi Company) and then 10 µg/kg/min will be infused intraoperative.
Sponsors
Vice Chancellor for research of Urmia University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:20 to 40 years old; patient with class I and II America society of Anesthesiologists; cesarean surgery with spinal anesthesia Exclusion criteria: any complaints of pruritus before surgery; start pruritus before closing cord; allergy to medications; preeclampsia; eclampsia; people who had used anti-nausea drug in the past 24 hours.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pruritus. Timepoint: During the surgery and recovery. Method of measurement: visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: During the surgery and recovery. Method of measurement: Has- does not have. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahryar Sane
Urmia University of Medical Sciences
Outcome results
None listed